Our investments

Biokinesis

Biokinesis, founded in October 2011, is a biotechnology company developing new treatments for cancer by targeting a specific kinesin found in several cancers. Biokinesis has so far had very good results on several types of animals.

Dr Philippe Pouletty and Antoine Pau are Board members.